|
Market Closed -
TEL AVIV STOCK EXCHANGE
15:26:21 02/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 113.00 ILa | -2.75% |
|
-0.18% | -62.41% |
Company Valuation: Evogene Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 71.23 | 26.16 | 42.08 | 13 | 8.219 | 5.685 | - | - |
| Change | - | -63.27% | 60.85% | -69.1% | -36.78% | -30.83% | - | - |
| Enterprise Value (EV) | 71.23 | 26.16 | 42.08 | 13 | 8.219 | 5.685 | 5.685 | 5.685 |
| Change | - | -63.27% | 60.85% | -69.1% | -36.78% | -30.83% | 0% | 0% |
| P/E | - | - | - | - | - | - | - | - |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 76.6x | 15.6x | 7.46x | 1.53x | 2.13x | 3.96x | 2.19x | 1.15x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 3.96x | 2.19x | 1.15x |
| EV / EBITDA | - | - | -0x | -0x | -0x | -0.63x | -0.64x | -0.62x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -0.56x | -0.56x | -0.53x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | - | - | - | - | - | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.93 | 1.675 | 5.64 | 8.511 | 3.853 | 1.436 | 2.6 | 4.95 |
| EBITDA 1 | - | - | -22.04 | -17.39 | -12.89 | -9.008 | -8.9 | -9.178 |
| EBIT 1 | -30.95 | -26.94 | -26.51 | -22.21 | -14.03 | -10.14 | -10.2 | -10.63 |
| Net income 1 | -27.79 | -26.64 | -23.88 | -16.48 | -8.485 | -12.17 | -10.2 | -10.63 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 53.750 | 22.350 | 29.980 | 7.269 | 3.006 | 1.130 | 1.130 | 1.130 |
| Nbr of stocks (in thousands) | 4,116 | 4,122 | 5,055 | 6,515 | 8,716 | 15,801 | - | - |
| Announcement Date | 10/03/22 | 09/03/23 | 07/03/24 | 06/03/25 | 05/03/26 | - | - | - |
1USD in Million2
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 5.84M | |
| 16.87x | 6.34x | 12.15x | 1.77% | 63.77B | |
| 30.14x | 8.25x | 27.02x | 0.04% | 56.37B | |
| 37.48x | 6.65x | 19.86x | 0.86% | 54.62B | |
| 34.85x | 3.31x | 14.29x | -.--% | 44.06B | |
| 48.85x | 5.63x | 30.81x | -.--% | 42.11B | |
| -19.86x | 192.36x | -21.16x | -.--% | 41B | |
| 47.33x | 8.41x | 28.18x | -.--% | 34.92B | |
| 32x | 8.13x | 21.15x | 0.41% | 32.82B | |
| -70.14x | 13.02x | -68.47x | -.--% | 24.7B | |
| Average | 17.50x | 28.01x | 7.09x | 0.34% | 39.43B | |
| Weighted average by Cap. | 21.73x | 26.34x | 11.23x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- EVGN Stock
- Valuation Evogene Ltd.
Select your edition
All financial news and data tailored to specific country editions
